Clinical Trial Update: Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

View source ↗

Summary

This clinical trial update reports completion of a newborn screening program for severe combined immunodeficiency (SCID) in a high-risk population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Combined Immunodeficiency
• T-cell Lymphocytopenia

Snippet

Sponsor: University of California, San Francisco | Conditions: Severe Combined Immunodeficiency, T Cell Lymphocytopenia | Status: COMPLETED